Mega caps comeback, China to curb loan growth, and fallout from Archegos Mega caps comeback, China to curb loan growth, and fallout from Archegos Mega caps comeback, China to curb loan growth, and fallout from Archegos

Mega caps comeback, China to curb loan growth, and fallout from Archegos

Equities 5 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Summary:  Mega caps is the best performing equity theme in April and the main reason for the recent momentum in broad equity markets. We take a look of the potential reasons behind the move. We also discussing China's is move to curb lending growth to its lowest growth rate in 15 years while simultaneously launching its new digital currency. Finally, we focus on Archegos and its impact on markets with Credit Suisse announcing losses of $4.7bn from the Archegos fallout.


We are back analysing equities following a long Danish holiday period. Over the past week, the most notable trend has been that of mega cap stocks (companies with a market value above $300bn) up 1.5% yesterday and 3.8% in April beating all other equity themes we are tracking. Why this sudden repricing of mega caps? One explanation is a move towards safety as mega caps are more diversified and less volatile offering protection. It could also be an inflation hedge as these companies have a much better chance of outgrowing inflation and thus protecting the capital of investors. Finally, the much stronger than expected US economic data, the Eurocoin Growth indicator in Europe has also never been higher, could also bolster expectations of a broad economic recovery which will shine on the world’s largest companies.

Is China’s lending curb a deal breaker on inflation?

Chinese banks have just reported Q4 earnings when Chinese regulators announced today that lending growth will be curbed to 11% this year the slowest increase in more than 15 years. This news comes as China is also announced the creation of its digital currency, the first for a major economy and potentially a threat to the US global reserve banking system. While the curb on lending is potentially a negative for our inflation outlook, our view is that the curb is mainly due to adequate stimulus coming from the US over the next year which will flow to China as the country exports a lot for the US economy. This will bolster growth in China regardless of domestic lending growth. In the end the ultimate catalyst on inflation will be physical constraints of metals and energy etc. The curb on lending is also wise given China’s relentless push to expand credit while the Chinese equity market has not approved the credit quality – this can be observed by the market cap to total assets ratio (see chart). This ratio expands when credit quality improves and falls when credit quality is deteriorating.

Did markets dodge a bullet on Archegos collapse?

The fallout of Archegos Capital Management is potentially losses of $7-10bn as highly leveraged total return swaps soured when Chinese technology stocks and other bets underperformed relative to benchmark equity indices in the US. Nomura and Credit Suisse are the biggest losers from the forced liquidation that started with Morgan Stanley and Goldman Sachs, with Credit Suisse announcing today $4.7bn in losses and cutting dividends while firing several key executives. What is up and down here, and is more coming?

First, it seems the risk from Archegos is contained with only downward pressure in selected positions and no contagion risks spreading to other parts of the equity market. While total return swaps have suddenly become a new word for many, they are quite simple instruments and used a lot as they are a cost-effective way of expressing relative performance between groups of equities. The biggest fallout from Archegos is that the losses came from a family office which are not heavily regulated and many failing hedge fund owners have recently transformed into family offices to avoid regulatory oversight giving more flexibility on position sizes etc. The likely result of Archegos is that prime brokerage businesses (the investment banking division that deals with large hedge funds providing securities lending and leverage etc.) will scale down risk in general and increased their scrutiny of the risk of family offices. Credit Suisse is continuing to sell large blocks of equities today in positions related to Archegos.

Source: Saxo Group
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.